HIV vaccines guide rare immune cells to make broadly neutralizing antibodies
Nature, Published online: 11 August 2026; doi:10.1038/d41586-026-02374-y Three studies in non-human primates show that strategically designed vaccines could prime a population of B cells to produce effective antibodies against HIV.
Three recent studies published in Nature provide a significant preclinical advancement towards developing an HIV vaccine. The researchers identified a novel approach that guides rare immune cells to produce broadly neutralizing antibodies, a crucial component in combating the virus. These studies, conducted by Guenaga et al., Marchitto et al., and Steichen et al., offer hope in the ongoing quest to create an effective HIV vaccine.
Written by urgent.news from Nature's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
